Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-000828
Filing Date
2021-06-24
Accepted
2021-06-24 17:46:11
Documents
1
Period of Report
2021-06-19

Document Format Files

Seq Description Document Type Size
1 matinasbio_fm4jun192021.html 4  
1 matinasbio_fm4jun192021.xml 4 7983
  Complete submission text file 0000905718-21-000828.txt   9378
Mailing Address C/O BIOENVISION, INC. 345 PARK AVENUE, 41ST. FLOOR NEW YORK NY 10154
Business Address
Scibetta James S (Reporting) CIK: 0001383242 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 211043927

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations